Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3772309012 | Amylase and endopeptidase and pancreatic lipase only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3772310019 | Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Is a | Product containing only amylase and endopeptidase and pancreatic lipase (medicinal product) | true | Inferred relationship | Some | ||
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Is a | Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Is a | Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Has active ingredient | Amylase (substance) | true | Inferred relationship | Some | 3 | |
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Has active ingredient | Endopeptidase | true | Inferred relationship | Some | 1 | |
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Has active ingredient | Pancreatic lipase | true | Inferred relationship | Some | 2 | |
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Plays role | Digestant therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Is a | True | Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR